mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.04 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.04 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |